Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
19 February 2015 |
Main ID: |
NCT01078935 |
Date of registration:
|
01/03/2010 |
Prospective Registration:
|
Yes |
Primary sponsor: |
|
Public title:
|
The Effect of Probiotics on the Rate of Recovery of Inflammatory Bowel Disease Exacerbation, Endothelial Function, and Markers of Inflammation
|
Scientific title:
|
The Effect of Probiotics on Bowel Disease |
Date of first enrolment:
|
December 2012 |
Target sample size:
|
100 |
Recruitment status: |
Not yet recruiting |
URL:
|
http://clinicaltrials.gov/show/NCT01078935 |
Study type:
|
Interventional |
Study design:
|
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Prevention
|
Phase:
|
Phase 4
|
|
Contacts
|
Name:
|
Arnon Blum, DR |
Address:
|
|
Telephone:
|
972466522688 |
Email:
|
ablum@poria.health.gov.il |
Affiliation:
|
|
| | |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- patients with ulcerative colitis and crohns' disease
Exclusion Criteria:.
- notable caveats are that arteries smaller than 2.5 mm
Age minimum:
18 Years
Age maximum:
80 Years
Gender:
Both
|
Health Condition(s) or Problem(s) studied
|
Ulcerative Colitis
|
Crohn's Disease
|
Intervention(s)
|
Dietary Supplement: placebo
|
Dietary Supplement: probiotics
|
Primary Outcome(s)
|
Crohn's disease activity index (CDAI)
[Time Frame: 2 years]
|
Truelove and Witts Classification of Ulcerative Colitis
[Time Frame: 2 years]
|
Secondary ID(s)
|
Prob-bl.CTIL
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|